Health Care Services

Hims & Hers Health

Bank of America Lowers Hims & Hers Price Target to $28 from $30

Hims & Hers Health Increases Convertible Note Offering to $350 Million

Hims & Hers debuts first AI agent, Labs AI

Law Firm Investigates Hims & Hers Health for Potential Corporate Wrongdoing

Hims & Hers Health Reports Net Loss in Q1 2026 Results, Leading to Stock Volatility

Hims & Hers Health expects to close its acquisition of Eucalyptus in mid-2026.

Investment group Susquehanna discloses a 6.5% passive stake in Hims & Hers

Hims & Hers reports Q1 earnings with an unexpected loss of $0.40 per share, but raises full-year revenue forecast

Capital World Investors discloses its stake in Hims & Hers

BofA Securities Lowers Price Target for Hims & Hers Health, Maintains Neutral Rating

Needham & Company Raises Hims & Hers Price Target Despite Earnings Miss

Hims & Hers Health Average Target Price Rises to $27.51

Morgan Stanley and Citibank Maintain Hold Rating on Hims & Hers Health

Hims & Hers Health Pivots to Branded Weight-Loss Drugs, International Revenue Grows Nearly Tenfold

HIMS Options Volume and Open Interest

JPMorgan Downgrades Hims & Hers Health's Price Target to $33

Hims & Hers Health released FY2026 Q1 earnings on May 11 After-Market (EST), actual revenue USD 608.1M (forecast USD 616.85M), actual EPS USD -0.4033 (forecast USD 0.0342)

Hims & Hers Health Anticipates Revenue Growth in Q2

Hims & Hers Health Misses Q1 Earnings Estimates, Shares Fall

Media reports on Hims & Hers Health's launch of an AI-powered care assistant named Labs AI

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

NextNRG

InMed Pharmaceuticals

Amesite

Meiwu Tech

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

CN Energy

MetaVia

Generation Income Properties

Co-Diagnostics

Pinned News

置顶新闻

Hims & Hers Massive Stock Drop Explained

Hims & Hers Health, Inc. (HIMS.US) Q1 2026 Earnings Conference Call

Hims & Hers Health, Inc. (HIMS.US) Q4 2025 Earnings Conference Call

Hims & Hers Health, Inc. (HIMS.US) Q3 2025 Earnings Conference Call

Hims & Hers Health, Inc. (HIMS.US) Q2 2025 Earnings Conference Call

HIMS

HIMZ

HIMY

Hims & Hers is raising $350 million through a convertible debt offering, which may limit shareholder dilution but also increases business risk. The company must demonstrate growth potential to the market, as the debt could either convert to stock or require cash repayment. This move aims to fund long-term growth plans.

nasdaq

Defiance Daily Target 2X Long HIMS ETF

VG Health

Defiance Leveraged Long +Income HIMS ETF

iShares US Healthcare Providers

SPDR S&P Health

NVIDIA

Intel

S&P 500

Nasdaq

NVIDIA Corporation

Bank of America has lowered its price target for Hims & Hers Health (NYSE:HIMS) from $30.00 to $28.00, maintaining a 'neutral' rating. This suggests a potential upside of 25.44% from the current price. Other analysts have also adjusted their ratings, with Morgan Stanley setting a target of $21.00 and Citigroup raising it to $28.00. Hims & Hers Health's stock is currently trading at $22.32.

Market Beat

iShares Global Healthcare

Bank of America

Morgan Stanley

Citigroup

Novo Nordisk AS

Eli Lilly

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Bank of America Lowers Hims & Hers Health (NYSE:HIMS) Price Target to $28.00

Hims has priced an upsized $350 million offering of 0.00% convertible senior notes due 2032, increased from $300 million. The funds will support international expansion and AI investments, with estimated net proceeds of approximately $338.5 million. The initial conversion rate is set at 33.8590 shares per $1,000 principal, reflecting a ~32.5% premium to the recent stock price.

TradingView

Hims prices $350M 0.00% convertible notes due 2032, upsized from $300M

Hims & Hers Health has upsized its private offering of 0% convertible senior notes to $350 million, increased from $300 million. The offering, due June 1, 2032, includes a 13-day option for initial purchasers to buy an additional $52.5 million. Proceeds will fund capped call transactions, support the acquisition of Eucalyptus, and cover general corporate purposes. The offering is expected to close Thursday.

Fidelity

Health Care Select Sector SPDR

Hims & Hers Health Prices Upsized $350 Million Notes Offering

On May 18, Eastern Time, Hims & Hers Health options saw a total of 131820 contracts traded, with calls accounting for 68% and puts making up 31%.

Options Flow

Trending | HIMS Plummets 11% on Monday, Some Put options Soar 550%

Hims & Hers Health(HIMS.US)

Hims & Hers Massive Stock Drop Explained

Bank of America Lowers Hims & Hers Health (NYSE:HIMS) Price Target to $28.00

Hims prices $350M 0.00% convertible notes due 2032, upsized from $300M

Hims & Hers Health Prices Upsized $350 Million Notes Offering

Trending | HIMS Plummets 11% on Monday, Some Put options Soar 550%